News
HealthDay on MSN1d
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor AgonistsMany Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose ...
Availability of GLP-1 receptor agonists with managed care organization (MCO) plans has remained under 60% since 2020. Access to tirzepatide (Mounjaro, Zepbound) was nearly completely restricted ...
CMS clawed back $13.2 million in money improperly sent to Molina Healthcare as a result of what the Justice Department ...
Most Medicaid managed care plans cover at least one FDA-approved medication for alcohol use disorder, but less than half covered all four, according to study results published in JAMA Network Open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback